UBS Group’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

UBS Group’s Portfolio GBIM Stock Details GBIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-215	Closed	–	–	8320
2016 Q2	$0	Sell	215 -1,560	-88%	-$2.77K	﹤0.01%	8264
2016 Q1	$4K	Buy	1,775 +691	+64%	+$1.5K	﹤0.01%	7148
2015 Q4	$4K	Buy	+1,084	New	+$3.47K	﹤0.01%	7831
2015 Q3	–	Sell	-274	Closed	-$1K	–	8909
2015 Q2	$1K	Sell	274 -278	-50%	-$1.73K	﹤0.01%	8387
2015 Q1	$4K	Sell	552 -306	-36%	-$2.21K	﹤0.01%	8274
2014 Q4	$7K	Buy	+858	New	+$5.98K	﹤0.01%	8760

Other funds holding GBIM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

UBS Group's GBIM Position: Q3 2016 in Review

UBS Group sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q3 2016, closing a stake of 215 shares.

UBS Group first reported a position in GBIM in Q4 2014 and held it in 6 quarters. The position peaked at $7K in Q4 2014. 1 fund tracked by Wall St. Rank holds GBIM as of Q3 2016.

UBS Group reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
UBS Group sold 215 GLOBEIMMUNE INC COM STK (DE) shares in Q3 2016.
UBS Group first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q4 2014 and held it in 6 quarters.
UBS Group's GLOBEIMMUNE INC COM STK (DE) position peaked at $7K in Q4 2014.
1 fund tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.